HOME >> MEDICINE >> NEWS
Second-generation antipsychotic medications appear to offer little advantage over older drugs

Among patients with schizophrenia whose medication is changed because of ineffectiveness or harmful side effects, second-generation antipsychotic drugs do not appear to offer significant benefits compared to first-generation antipsychotic drugs, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals. The findings run contrary to the widely held perception that second-generation antipsychotic agents are safer and more effective in treating patients with schizophrenia than the less-expensive first-generation class of medications.

For almost 50 years, antipsychotic medications have been the primary method of treating schizophrenia, a psychiatric disorder that causes a disconnect from reality and severe disturbances in thought, mood and behavior. Patients taking first-generation antipsychotics--so called because they were developed first--often relapse or develop severe side effects, including sedation (feeling tranquilized) and involuntary muscle movements, according to background information in the article. The development of second-generation antipsychotics was thought to be a major advance primarily because the drugs reduced such side effects. Claims that second-generation drugs are more effective than first-generation drugs have shifted treatment patterns away from first-generation medications, although research comparing the drug classes has had mixed results.

Peter B. Jones, M.D., Ph.D., University of Cambridge and Cambridgeshire and Peterborough Mental Health NHS Trust, Cambridge, England, and colleagues studied 227 individuals age 18 to 65 with schizophrenia. "The key question was whether the additional acquisition costs of second-generation antipsychotics over first-generation antipsychotics would be offset by improvements in health-related quality of life or savings in the use of other health and social care services in people with schizophrenia for whom a change in drug trea
'"/>

Contact: Peter B. Jones, M.D., Ph.D.
pbj21@cam.ac.uk
JAMA and Archives Journals
2-Oct-2006


Page: 1 2 3 4

Related medicine news :

1. USC-led study suggests little benefit from antipsychotics in Alzheimers
2. Most effective antipsychotic drug has serious health consequences
3. Number of children and teens treated with antipsychotics increases sharply
4. Atypical antipsychotic drugs for dementia may be associated with small increased risk of death
5. NIMH study finds antipsychotic Risperidone safe, effective as intermediate term treatment for autism
6. Metabolic side effects of antipsychotics are known, but rarely monitored
7. Different antipsychotic medications may have different effects on brain volume
8. Study shows new antipsychotic drug prevents brain loss in schizophrenia
9. Commonly used pain medications do not prevent Alzheimers disease
10. Standard long-acting insulin as good as newer medications
11. MS patients not receiving medications to slow disease progression, research shows

Post Your Comments:
(Date:5/29/2015)... organizational consultant and part-time college professor, Dr. Ben Parks ... be suffering from early dementia. He is embarrassed at ... his uncertain relationship with his wife Addie. , Ben ... and government movers and shakers as they wrestle with ... are being diagnosed with Alzheimer’s, Ben wonders what’s in ...
(Date:5/29/2015)... 29, 2015 The world of dentistry had ... depicted dentists as sadists who dispense pain to people unfortunate ... What's more, when it came to surgeries, people would have ... ­ but that's all back in the 20th Century now. ... practice in the Sheepshead Bay neighborhood of Brooklyn, ...
(Date:5/29/2015)... DISC, a method of behavioral analysis that ... used by companies to improve hiring practices, streamline training, ... an out-of-the-box practice, has now become an integral part ... Society for Human Resource Management found that over 70% ... be an essential part of the hiring process, and ...
(Date:5/29/2015)... Hurst, Texas (PRWEB) May 29, 2015 Testosterone ... in the DFW area, is opening a new center in ... and the rest of the Mid Cities. Located on the ... Line Road in Hurst, the new testosterone center will open ... and women who suffer from low testosterone. , Like TCT’s ...
(Date:5/29/2015)... 2015 Wimbledon Health Partners, the leading ... echocardiogram and NCV testing, is proud to announce ... for EKG interpretation of athletes. , Sudden ... during athletic activity. New findings presented in February have ... improve cardiac safety in athletes. Physiologic adaptations in athletic ...
Breaking Medicine News(10 mins):Health News:‘Forgetful’ Professor Struggles With Dementia in Compelling New Novel 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4Health News:PeopleKeys to Air a Follow-up to Their Popular DISC Trainer’s Toolbox Webinar, Featuring All-New Content and Strategies 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 2Health News:Wimbledon Health Partners Incorporates Updated ‘Seattle Criteria’ for EKG Interpretation of Athletes 3
(Date:5/28/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report  "Personalized Medicine ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The aim ... to match the right drug to the ... to design the appropriate treatment for a ...
(Date:5/28/2015)... ALEXANDRIA, Va. , May 28, 2015 ... Hoey , RPh, MBA issued the following statement in ... the AARP Public Policy Institute documenting that a number ... "This new report tracks with concerns previously expressed ... Congress to support patient access to essential medications. Moreover, ...
(Date:5/28/2015)... YORK , May 27, 2015 The ... $416 billion in 2014 and with growth of 8% ... three categories out of pocket: directly on expenditures, co-pays ... drug purchases, and on premiums.  The publisher made its ... Expenditures in the United States ...
Breaking Medicine Technology:Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3
Cached News: